WELCOME TO The Biotechnology REPORT
Newsletter | Member Login | Signup
Home > Resources > Whitepapers > A New Generation of Cancer Immunotherapies
June 9, 2022
I'm For Real
Enter your details once to access all our information and resources
AgReliant Genetics, headquartered in Westfield, IN, has established itself as a leader in seed research, production, and quality, becoming one of the fastest growing independent seed companies in the industry.
whitePaper | June 8, 2022
For nearly two decades, the Future Today Institute has meticulously researched macro forces of change and the emerging trends that result. Our focus: understanding how these forces and trends will shape our futures.
Sequencing of human genomes is fast becoming an affordable technology for general consumer.
whitePaper | March 22, 2022
The Clinical Trials Regulation has retained some definitions and refined others. For example the definition of “clinical study”: “Any investigation in relation to humans intended: (a) to discover or verify the clinical, pharmacological or other pharmacodynamic.
whitePaper | April 14, 2022
In the nearly 50 years since the first genetic engineering experiments, the United States has become the world’s biotechnology powerhouse,
whitePaper | October 12, 2022
Advanced therapy medicinal products cell and gene therapies offer tremendous hope for patients either by actually curing serious diseases or by alleviating suffering.
whitePaper | April 24, 2023
Despite challenging global conditions, the Swiss biotech industry was able to raise more than CHF 1.33 billion in 2022, with roughly CHF 0.78 billion collected by public companies and the remaining CHF 0.55 billion collected by private companies.
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Welcome back!
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up
Sign up to contribute and publish your news, events, brand, and content with the community for FREE